DNAPrint Genomics, Inc.
DNAGOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$12892
P/E Ratio—
52W High$0.00002
52W Low$0.000001
DNAPrint Genomics, Inc. (DNAG) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · DNAG · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2006-12 | 2005-12 | 2004-12 | 2003-12 | 2002-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.43M | $1.28M | $0.79M | $0.71M | $0.18M |
| Cost of Revenue | $1.68M | $0.95M | $0.51M | $0.43M | $0.07M |
| Gross Profit | $0.75M | $0.33M | $0.28M | $0.28M | $0.11M |
| Gross Margin %(computed) | 30.99% | 25.48% | 35.35% | 39.09% | 60.33% |
| Operating Expenses | |||||
| R&D Expenses | $6.43M | $2.12M | $1.56M | $2.65M | $2.20M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | ($8.11M) | ($4.34M) | ($3.06M) | ($5.96M) | ($2.50M) |
| Operating Income | ($8.87M) | ($4.66M) | $3.33M | $6.23M | $2.61M |
| Operating Margin %(computed) | -364.45% | -365.50% | 424.42% | 878.58% | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($12.35M) | ($8.72M) | ($3.73M) | ($7.79M) | ($3.11M) |
| Net Margin %(computed) | -507.54% | -683.33% | -475.41% | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.03 | $-0.09 | $-0.20 | $-3.20 | $-0.14 |
| Wtd Avg Shares | 365.24M | 93.53M | 35.37M | 24.98M | 22.57M |
| EBITDA | ($8.93M) | ($2.38M) | ($2.28M) | ($5.19M) | ($2.16M) |
| EBITDA Margin %(computed) | -367.02% | -186.25% | -290.55% | -732.03% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more DNAPrint Genomics, Inc. data
About DNAPrint Genomics, Inc. (DNAG) Income Statement
DNAPrint Genomics, Inc. (DNAG) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2006, DNAG reported revenue of $0.00B, gross profit of $0.00B (gross margin 30.99%), and net income of ($0.01B) — a net profit margin of -507.54%.
Frequently asked questions
DNAG · 4 questionsDNAPrint Genomics, Inc. (DNAG) reported revenue of $0.00B for 2006, up 90.7% year-over-year.
DNAG revenueDNAG salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09